 Austin Larson
Concepts (302)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 11 | 2023 | 110 | 2.350 |
Why?
| | Intellectual Disability | 8 | 2024 | 127 | 2.010 |
Why?
| | Abnormalities, Multiple | 7 | 2024 | 176 | 1.550 |
Why?
| | Mutation | 13 | 2022 | 3338 | 1.180 |
Why?
| | Bone Diseases, Developmental | 2 | 2024 | 12 | 1.000 |
Why?
| | Mitochondrial Encephalomyopathies | 2 | 2020 | 8 | 0.860 |
Why?
| | Mitochondria | 6 | 2020 | 744 | 0.780 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 2 | 2020 | 17 | 0.770 |
Why?
| | Phenotype | 16 | 2023 | 2784 | 0.760 |
Why?
| | Diet, Ketogenic | 3 | 2021 | 33 | 0.750 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 12 | 0.690 |
Why?
| | Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2019 | 6 | 0.670 |
Why?
| | Gray Matter | 1 | 2019 | 67 | 0.640 |
Why?
| | Dystroglycans | 1 | 2018 | 7 | 0.610 |
Why?
| | Qb-SNARE Proteins | 1 | 2018 | 6 | 0.610 |
Why?
| | Multiple Carboxylase Deficiency | 1 | 2018 | 1 | 0.600 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 36 | 0.600 |
Why?
| | Congenital Disorders of Glycosylation | 3 | 2023 | 4 | 0.590 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 82 | 0.570 |
Why?
| | Seizures | 5 | 2023 | 337 | 0.500 |
Why?
| | Hypopituitarism | 1 | 2015 | 15 | 0.490 |
Why?
| | Adrenal Insufficiency | 3 | 2021 | 26 | 0.460 |
Why?
| | Magnetic Resonance Imaging | 6 | 2020 | 3039 | 0.460 |
Why?
| | Infant | 15 | 2023 | 7943 | 0.430 |
Why?
| | Prilocaine | 1 | 2013 | 3 | 0.430 |
Why?
| | Cephalometry | 1 | 2013 | 28 | 0.430 |
Why?
| | Liver Transplantation | 1 | 2020 | 695 | 0.420 |
Why?
| | Dystocia | 1 | 2013 | 9 | 0.420 |
Why?
| | Methemoglobinemia | 1 | 2013 | 13 | 0.420 |
Why?
| | Lidocaine | 1 | 2013 | 40 | 0.420 |
Why?
| | Sexual Development | 1 | 2012 | 19 | 0.410 |
Why?
| | Fetal Macrosomia | 1 | 2013 | 58 | 0.410 |
Why?
| | Shoulder | 1 | 2013 | 84 | 0.410 |
Why?
| | Anesthetics, Local | 1 | 2013 | 81 | 0.400 |
Why?
| | Genetic Association Studies | 4 | 2022 | 339 | 0.400 |
Why?
| | Humans | 49 | 2024 | 114043 | 0.340 |
Why?
| | Glycosylation | 5 | 2023 | 130 | 0.340 |
Why?
| | Female | 31 | 2023 | 59325 | 0.340 |
Why?
| | Child, Preschool | 15 | 2022 | 9114 | 0.330 |
Why?
| | Mitochondrial Diseases | 2 | 2020 | 76 | 0.310 |
Why?
| | Epilepsy | 3 | 2023 | 278 | 0.310 |
Why?
| | Transcription Factors | 4 | 2022 | 1525 | 0.300 |
Why?
| | Genetic Testing | 4 | 2023 | 381 | 0.300 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 2019 | 7 | 0.290 |
Why?
| | Developmental Disabilities | 2 | 2020 | 236 | 0.280 |
Why?
| | Genetic Variation | 3 | 2021 | 868 | 0.280 |
Why?
| | Genetic Predisposition to Disease | 4 | 2019 | 2090 | 0.280 |
Why?
| | Male | 27 | 2022 | 55396 | 0.280 |
Why?
| | Nerve Tissue Proteins | 2 | 2021 | 527 | 0.280 |
Why?
| | Child | 21 | 2024 | 18400 | 0.270 |
Why?
| | Mitochondrial Proteins | 2 | 2020 | 213 | 0.270 |
Why?
| | Heterozygote | 5 | 2021 | 250 | 0.270 |
Why?
| | Nuclear Proteins | 2 | 2022 | 591 | 0.270 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 322 | 0.260 |
Why?
| | Carrier Proteins | 2 | 2019 | 694 | 0.250 |
Why?
| | Actins | 2 | 2019 | 376 | 0.240 |
Why?
| | Nervous System Malformations | 2 | 2022 | 33 | 0.240 |
Why?
| | Adolescent | 11 | 2022 | 17800 | 0.240 |
Why?
| | Loss of Function Mutation | 2 | 2021 | 36 | 0.230 |
Why?
| | Metabolism, Inborn Errors | 2 | 2021 | 39 | 0.230 |
Why?
| | Sotos Syndrome | 1 | 2024 | 1 | 0.230 |
Why?
| | Xanthomatosis, Cerebrotendinous | 1 | 2023 | 2 | 0.230 |
Why?
| | Septo-Optic Dysplasia | 1 | 2024 | 4 | 0.230 |
Why?
| | Autistic Disorder | 2 | 2023 | 160 | 0.220 |
Why?
| | Megalencephaly | 1 | 2024 | 15 | 0.220 |
Why?
| | Craniofacial Abnormalities | 1 | 2024 | 59 | 0.220 |
Why?
| | Chromosome Disorders | 1 | 2023 | 35 | 0.220 |
Why?
| | Aldehyde Reductase | 1 | 2023 | 24 | 0.210 |
Why?
| | Chromosome Deletion | 2 | 2023 | 94 | 0.210 |
Why?
| | Vestibular Diseases | 1 | 2023 | 22 | 0.210 |
Why?
| | Infant, Newborn | 6 | 2022 | 5038 | 0.200 |
Why?
| | Zebrafish | 2 | 2023 | 412 | 0.200 |
Why?
| | Hematologic Diseases | 1 | 2023 | 55 | 0.200 |
Why?
| | Cerebellar Diseases | 1 | 2022 | 21 | 0.200 |
Why?
| | RNA, Transfer | 2 | 2020 | 118 | 0.200 |
Why?
| | Phosphoproteins | 2 | 2021 | 293 | 0.200 |
Why?
| | De Lange Syndrome | 1 | 2022 | 2 | 0.200 |
Why?
| | Fibroblasts | 4 | 2020 | 834 | 0.200 |
Why?
| | Amino Acid Substitution | 2 | 2020 | 261 | 0.200 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2020 | 437 | 0.200 |
Why?
| | Transposases | 1 | 2022 | 9 | 0.200 |
Why?
| | Rhodanine | 1 | 2021 | 1 | 0.200 |
Why?
| | Phosphotransferases (Phosphomutases) | 1 | 2021 | 2 | 0.200 |
Why?
| | Thiazolidines | 1 | 2021 | 7 | 0.200 |
Why?
| | Dwarfism | 1 | 2021 | 15 | 0.190 |
Why?
| | Sorbitol | 1 | 2021 | 15 | 0.190 |
Why?
| | Wolf-Hirschhorn Syndrome | 1 | 2021 | 1 | 0.190 |
Why?
| | Metabolism | 1 | 2021 | 35 | 0.190 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 92 | 0.180 |
Why?
| | Methionine | 1 | 2021 | 144 | 0.180 |
Why?
| | Drosophila Proteins | 1 | 2022 | 164 | 0.180 |
Why?
| | Vitamin B 12 | 1 | 2021 | 115 | 0.180 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2021 | 100 | 0.180 |
Why?
| | Adrenal Hyperplasia, Congenital | 1 | 2021 | 28 | 0.180 |
Why?
| | Prenatal Care | 1 | 2023 | 250 | 0.180 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2020 | 8 | 0.180 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 227 | 0.180 |
Why?
| | Receptors, CCR4 | 1 | 2020 | 15 | 0.180 |
Why?
| | Aldehyde-Lyases | 1 | 2020 | 2 | 0.180 |
Why?
| | Nephrosis | 1 | 2020 | 4 | 0.180 |
Why?
| | Vitamin B 6 | 1 | 2020 | 9 | 0.180 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 22 | 0.170 |
Why?
| | Membrane Proteins | 2 | 2023 | 1016 | 0.170 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 722 | 0.170 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.170 |
Why?
| | Mucolipidoses | 1 | 2020 | 7 | 0.170 |
Why?
| | Leigh Disease | 1 | 2020 | 17 | 0.170 |
Why?
| | Myotonin-Protein Kinase | 1 | 2020 | 1 | 0.170 |
Why?
| | Quinone Reductases | 1 | 2020 | 15 | 0.170 |
Why?
| | Thymidine | 1 | 2020 | 58 | 0.170 |
Why?
| | ATP-Dependent Proteases | 1 | 2020 | 1 | 0.170 |
Why?
| | Tumor Suppressor Proteins | 1 | 2022 | 283 | 0.170 |
Why?
| | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2020 | 2 | 0.170 |
Why?
| | Lymphopenia | 1 | 2020 | 49 | 0.170 |
Why?
| | Muscular Diseases | 1 | 2020 | 104 | 0.170 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2021 | 96 | 0.170 |
Why?
| | Tyrosine | 1 | 2020 | 210 | 0.170 |
Why?
| | Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 3 | 0.170 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 23 | 0.170 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 40 | 0.170 |
Why?
| | HEK293 Cells | 1 | 2022 | 590 | 0.170 |
Why?
| | Mutagenesis, Insertional | 1 | 2019 | 61 | 0.170 |
Why?
| | Albinism | 1 | 2019 | 2 | 0.170 |
Why?
| | Lysosomal Storage Diseases | 1 | 2019 | 4 | 0.160 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 182 | 0.160 |
Why?
| | Acids | 1 | 2019 | 16 | 0.160 |
Why?
| | Scoliosis | 1 | 2021 | 178 | 0.160 |
Why?
| | Proteolysis | 1 | 2020 | 142 | 0.160 |
Why?
| | Oligonucleotides, Antisense | 1 | 2019 | 100 | 0.160 |
Why?
| | Chloride Channels | 1 | 2019 | 35 | 0.160 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 120 | 0.160 |
Why?
| | Rare Diseases | 1 | 2019 | 88 | 0.160 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2018 | 56 | 0.160 |
Why?
| | Galactosyltransferases | 1 | 2018 | 11 | 0.160 |
Why?
| | Bronchiectasis | 1 | 2020 | 106 | 0.160 |
Why?
| | Fetus | 1 | 2023 | 698 | 0.160 |
Why?
| | Leukoencephalopathies | 1 | 2018 | 21 | 0.160 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2018 | 14 | 0.160 |
Why?
| | Lysosomes | 1 | 2019 | 123 | 0.160 |
Why?
| | Spasms, Infantile | 1 | 2020 | 103 | 0.160 |
Why?
| | Molecular Chaperones | 1 | 2020 | 156 | 0.150 |
Why?
| | Membrane Transport Proteins | 1 | 2019 | 138 | 0.150 |
Why?
| | Arginine | 1 | 2019 | 236 | 0.150 |
Why?
| | Enzyme Inhibitors | 1 | 2021 | 743 | 0.150 |
Why?
| | Trachea | 1 | 2020 | 223 | 0.150 |
Why?
| | Ubiquinone | 1 | 2018 | 21 | 0.150 |
Why?
| | Cellular Senescence | 1 | 2019 | 151 | 0.150 |
Why?
| | Nerve Degeneration | 1 | 2018 | 41 | 0.150 |
Why?
| | Ataxia | 1 | 2018 | 35 | 0.150 |
Why?
| | Metalloendopeptidases | 1 | 2018 | 54 | 0.150 |
Why?
| | Gene Expression | 2 | 2020 | 1417 | 0.150 |
Why?
| | Nephrotic Syndrome | 1 | 2018 | 24 | 0.150 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2018 | 34 | 0.150 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2020 | 519 | 0.150 |
Why?
| | Phenylalanine-tRNA Ligase | 1 | 2017 | 2 | 0.150 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2017 | 6 | 0.150 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 83 | 0.150 |
Why?
| | Carnitine | 1 | 2018 | 62 | 0.140 |
Why?
| | Muscle Weakness | 1 | 2018 | 81 | 0.140 |
Why?
| | Catalytic Domain | 1 | 2018 | 196 | 0.140 |
Why?
| | Adult | 11 | 2022 | 30375 | 0.140 |
Why?
| | Pregnancy | 5 | 2023 | 5499 | 0.140 |
Why?
| | Colon | 2 | 2019 | 232 | 0.140 |
Why?
| | Urinary Bladder | 2 | 2019 | 161 | 0.130 |
Why?
| | Dietary Supplements | 1 | 2020 | 459 | 0.130 |
Why?
| | Cardiomyopathies | 1 | 2020 | 298 | 0.130 |
Why?
| | Young Adult | 6 | 2022 | 10444 | 0.130 |
Why?
| | Precision Medicine | 1 | 2019 | 335 | 0.130 |
Why?
| | Brain | 4 | 2020 | 2355 | 0.120 |
Why?
| | Holoprosencephaly | 1 | 2015 | 8 | 0.120 |
Why?
| | Diabetes Insipidus | 1 | 2015 | 7 | 0.120 |
Why?
| | Muscle, Skeletal | 3 | 2020 | 1468 | 0.120 |
Why?
| | Human Growth Hormone | 1 | 2015 | 38 | 0.120 |
Why?
| | Thyrotropin | 1 | 2015 | 100 | 0.120 |
Why?
| | Histones | 1 | 2019 | 529 | 0.120 |
Why?
| | Hypogonadism | 1 | 2015 | 75 | 0.120 |
Why?
| | RNA | 1 | 2020 | 807 | 0.110 |
Why?
| | Mutation, Missense | 3 | 2021 | 294 | 0.110 |
Why?
| | Cephalopelvic Disproportion | 1 | 2013 | 2 | 0.110 |
Why?
| | Vacuum Extraction, Obstetrical | 1 | 2013 | 3 | 0.110 |
Why?
| | Port-Wine Stain | 1 | 2013 | 2 | 0.110 |
Why?
| | Rhode Island | 1 | 2013 | 23 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1880 | 0.110 |
Why?
| | Brachial Plexus | 1 | 2013 | 28 | 0.100 |
Why?
| | WT1 Proteins | 1 | 2012 | 12 | 0.100 |
Why?
| | Administration, Topical | 1 | 2013 | 137 | 0.100 |
Why?
| | SOX9 Transcription Factor | 1 | 2012 | 23 | 0.100 |
Why?
| | RNA Splicing Factors | 1 | 2012 | 49 | 0.100 |
Why?
| | Drosophila | 2 | 2023 | 133 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2022 | 3003 | 0.090 |
Why?
| | Cohort Studies | 2 | 2018 | 4883 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2020 | 12521 | 0.090 |
Why?
| | Urban Population | 1 | 2013 | 396 | 0.090 |
Why?
| | Syndrome | 2 | 2022 | 330 | 0.090 |
Why?
| | Electron Transport Complex IV | 2 | 2020 | 53 | 0.090 |
Why?
| | Haploinsufficiency | 2 | 2020 | 42 | 0.090 |
Why?
| | Oxidative Phosphorylation | 2 | 2020 | 154 | 0.080 |
Why?
| | DNA Mutational Analysis | 2 | 2021 | 373 | 0.080 |
Why?
| | Diabetes, Gestational | 1 | 2013 | 281 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1331 | 0.080 |
Why?
| | Electron Transport | 2 | 2020 | 108 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 801 | 0.070 |
Why?
| | Biomarkers | 3 | 2021 | 3397 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2021 | 926 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1311 | 0.060 |
Why?
| | Biopsy | 2 | 2019 | 1024 | 0.060 |
Why?
| | Exome | 2 | 2017 | 200 | 0.060 |
Why?
| | Animals | 5 | 2023 | 31565 | 0.060 |
Why?
| | NFI Transcription Factors | 1 | 2024 | 5 | 0.060 |
Why?
| | Cholestanetriol 26-Monooxygenase | 1 | 2023 | 5 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2022 | 2550 | 0.060 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2023 | 15 | 0.050 |
Why?
| | Mannose | 1 | 2023 | 21 | 0.050 |
Why?
| | Exons | 1 | 2024 | 301 | 0.050 |
Why?
| | Histone Demethylases | 1 | 2023 | 28 | 0.050 |
Why?
| | Workflow | 1 | 2023 | 132 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 16 | 0.050 |
Why?
| | Muscle Hypotonia | 1 | 2021 | 31 | 0.050 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 20 | 0.050 |
Why?
| | Neuroglia | 1 | 2022 | 149 | 0.050 |
Why?
| | Patient Acuity | 1 | 2021 | 42 | 0.050 |
Why?
| | Language Development Disorders | 1 | 2021 | 38 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 350 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 388 | 0.050 |
Why?
| | Hepatocytes | 1 | 2022 | 195 | 0.050 |
Why?
| | Face | 1 | 2023 | 163 | 0.050 |
Why?
| | Homocysteine | 1 | 2021 | 137 | 0.050 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 225 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2021 | 122 | 0.040 |
Why?
| | Methylation | 1 | 2021 | 208 | 0.040 |
Why?
| | Transferrin | 1 | 2020 | 39 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 217 | 0.040 |
Why?
| | Feeding and Eating Disorders | 1 | 2021 | 103 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2020 | 27 | 0.040 |
Why?
| | Acyl-CoA Dehydrogenase | 1 | 2020 | 8 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2020 | 27 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2020 | 14 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 150 | 0.040 |
Why?
| | Risk Factors | 1 | 2013 | 8614 | 0.040 |
Why?
| | Heme | 1 | 2020 | 52 | 0.040 |
Why?
| | Protein Stability | 1 | 2020 | 156 | 0.040 |
Why?
| | Cell Nucleolus | 1 | 2019 | 17 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 187 | 0.040 |
Why?
| | Facies | 1 | 2019 | 20 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2022 | 367 | 0.040 |
Why?
| | Drugs, Investigational | 1 | 2019 | 30 | 0.040 |
Why?
| | Phosphates | 1 | 2020 | 155 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 94 | 0.040 |
Why?
| | Leukemia | 1 | 2021 | 208 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 196 | 0.040 |
Why?
| | 14-3-3 Proteins | 1 | 2018 | 13 | 0.040 |
Why?
| | Aneuploidy | 1 | 2019 | 84 | 0.040 |
Why?
| | Xenopus laevis | 1 | 2019 | 115 | 0.040 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 20 | 0.040 |
Why?
| | Brain Diseases | 1 | 2020 | 124 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2019 | 92 | 0.040 |
Why?
| | Nutritional Status | 1 | 2021 | 286 | 0.040 |
Why?
| | Enzyme Assays | 1 | 2018 | 21 | 0.040 |
Why?
| | Drug Discovery | 1 | 2019 | 123 | 0.040 |
Why?
| | Metabolomics | 1 | 2023 | 511 | 0.040 |
Why?
| | Weight Gain | 1 | 2021 | 453 | 0.040 |
Why?
| | Oocytes | 1 | 2019 | 169 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 549 | 0.040 |
Why?
| | Dermis | 1 | 2018 | 30 | 0.040 |
Why?
| | Iron-Sulfur Proteins | 1 | 2018 | 24 | 0.040 |
Why?
| | Aminoacylation | 1 | 2017 | 12 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 507 | 0.040 |
Why?
| | Electroencephalography | 1 | 2019 | 359 | 0.040 |
Why?
| | Microtubule-Associated Proteins | 1 | 2018 | 171 | 0.040 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2017 | 28 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 564 | 0.040 |
Why?
| | Neuroimaging | 1 | 2019 | 249 | 0.040 |
Why?
| | Alleles | 1 | 2020 | 789 | 0.040 |
Why?
| | Genomics | 1 | 2022 | 633 | 0.040 |
Why?
| | Caregivers | 1 | 2023 | 713 | 0.040 |
Why?
| | Pedigree | 1 | 2018 | 460 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 917 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1547 | 0.030 |
Why?
| | Family | 1 | 2020 | 589 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 899 | 0.030 |
Why?
| | Chromatin | 1 | 2019 | 424 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 1981 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 182 | 0.030 |
Why?
| | Child Development | 1 | 2019 | 384 | 0.030 |
Why?
| | Mice | 2 | 2023 | 14841 | 0.030 |
Why?
| | DNA Methylation | 1 | 2019 | 493 | 0.030 |
Why?
| | Skin | 1 | 2019 | 653 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2018 | 333 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2017 | 587 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1757 | 0.030 |
Why?
| | Liver | 1 | 2022 | 1633 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2018 | 476 | 0.030 |
Why?
| | Prognosis | 1 | 2021 | 3315 | 0.030 |
Why?
| | Muscle, Smooth | 1 | 2014 | 142 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2018 | 538 | 0.020 |
Why?
| | Kidney | 1 | 2018 | 1182 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2272 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 26605 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 3861 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2505 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2018 | 9049 | 0.010 |
Why?
| | Aged | 1 | 2021 | 18969 | 0.010 |
Why?
|
|
Larson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|